DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Zydus Lifesciences Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·30 Jul 2026, 11:48 am

Zydus Lifesciences

Zydus Lifesciences has announced that it will host an institutional investor meet or conference call. This event is a standard platform for a company to present its business strategy, recent performance, and future outlook directly to analysts and investors.

For the retail investor, this update signals that the company is proactively engaging with the market. It provides an opportunity to understand management's perspective on growth drivers and operational efficiency, which can be valuable for assessing the company's trajectory.

Investors should watch for key disclosures regarding product pipelines, revenue guidance, or any strategic shifts discussed during the session. This information will help gauge the company's confidence in its upcoming business cycle.